Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. - Eriksson,B.I.; Dahl,O.E.; Rosencher,N. (J Thromb Haemost, 2007)